S, L., V, P., L, F., M, B., F, B., A, T., . . . A, Z. (2025). ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent transcription replication conflicts in triple negative breast cancer. Nature communications, 16(1), 4602. https://doi.org/10.1038/s41467-025-59804-0
Chicago Style (17th ed.) CitationS, Lago, et al. "ANP32E Drives Vulnerability to ATR Inhibitors by Inducing R-loops-dependent Transcription Replication Conflicts in Triple Negative Breast Cancer." Nature Communications 16, no. 1 (2025): 4602. https://doi.org/10.1038/s41467-025-59804-0.
MLA (9th ed.) CitationS, Lago, et al. "ANP32E Drives Vulnerability to ATR Inhibitors by Inducing R-loops-dependent Transcription Replication Conflicts in Triple Negative Breast Cancer." Nature Communications, vol. 16, no. 1, 2025, p. 4602, https://doi.org/10.1038/s41467-025-59804-0.